First Trust Nasdaq Pharmaceuticals ETF (FTXH) Holdings $27.99 +0.12 (+0.42%) As of 02/21/2025 03:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Holdings Stock AnalysisChartDividendHoldingsOptions ChainOwnershipRatingsShort InterestTrends Top 50 FTXH HoldingsRankCompanyCurrent PriceWeightShares Held1BMYBristol-Myers Squibb$55.85+0.1%8.75%23,4012ABBVAbbVie$202.03+0.6%7.64%5,9543JNJJohnson & Johnson$162.35+1.7%7.36%7,0484PFEPfizer$26.32+1.6%6.88%40,2945MRKMerck & Co., Inc.$89.40+2.0%5.71%9,8686GILDGilead Sciences$109.95-0.1%4.76%7,3997CAHCardinal Health$126.96-0.3%4.45%5,1858JAZZJazz Pharmaceuticals$136.01-0.5%3.72%4,2779ZTSZoetis$160.39+1.9%3.71%3,18610UTHRUnited Therapeutics$361.10-1.7%3.67%1,553 Get the Latest News and Ratings for FTXH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 11LLYEli Lilly and Company$874.12+0.1%3.52%60812AMGNAmgen$303.01+1.7%3.47%1,75113VTRSViatris$11.25+1.7%3.43%48,38214BIIBBiogen$140.64+2.6%2.66%2,84915OGNOrganon & Co.$15.47-1.4%2.44%24,41816REGNRegeneron Pharmaceuticals$700.33+0.6%2.19%49217CRLCharles River Laboratories International$163.11+0.5%2.00%1,93018MEDPMedpace$340.78-1.2%1.80%82319ELANElanco Animal Health$11.02-1.0%1.53%20,03620NBIXNeurocrine Biosciences$120.69+3.9%1.36%1,73921HALOHalozyme Therapeutics$57.75+0.5%1.30%3,39622ALKSAlkermes$35.33-0.5%1.23%5,77123EXELExelixis$36.85+5.0%1.08%4,91724CORTCorcept Therapeutics$63.54-2.4%1.05%2,29625PBHPrestige Consumer Healthcare$84.66-0.1%1.04%1,81626ITCIIntra-Cellular Therapies$128.60+0.0%0.94%1,10527PRGOPerrigo$25.37+0.5%0.90%5,55628TGTXTG Therapeutics$30.88-0.2%0.72%3,45029ALNYAlnylam Pharmaceuticals$250.59-0.2%0.69%38630PTGXProtagonist Therapeutics$38.75+0.7%0.65%2,64331ACADACADIA Pharmaceuticals$19.95-1.7%0.60%4,88732VCELVericel$52.00-4.3%0.60%1,56933BPMCBlueprint Medicines$92.25-2.2%0.58%84834TWSTTwist Bioscience$41.31-8.4%0.58%1,87435INSMInsmed$81.06-3.0%0.57%1,06036INCYIncyte$72.05+0.9%0.55%1,23437ADMAADMA Biologics$15.84-1.5%0.50%4,68038AMRXAmneal Pharmaceuticals$7.83-0.5%0.50%9,35739ACLXArcellx$63.75-2.8%0.50%1,17940VRTXVertex Pharmaceuticals$484.24+0.8%0.50%163Buy this AI Stock Before Elon’s Announcement (Ad)With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dust. This isn't just a prediction; it's a calculated shift backed by political support, policy changes, and Musk's proven track record. I've identified a company that is quietly enabling xAI's rapid growth.Click here to watch my presentation and learn how to invest today.41ROIVRoivant Sciences$10.68-0.4%0.46%6,62642EXASExact Sciences$49.26-0.5%0.45%1,31443SRPTSarepta Therapeutics$106.28-2.0%0.44%59744RNAAvidity Biosciences$31.12-4.3%0.42%1,84245BMRNBioMarin Pharmaceutical$68.25-0.7%0.42%99746KRYSKrystal Biotech$187.86+2.9%0.42%41547KYMRKymera Therapeutics$36.81-1.6%0.39%1,67648IONSIonis Pharmaceuticals$32.33-1.1%0.36%1,69949VKTXViking Therapeutics$34.07+7.7%0.25%1,26450MYGNMyriad Genetics$14.19-5.3%0.24%2,860 Geographic ExposureUnited States93.2%Ireland6.1%Bermuda0.5%Currency ExposureUSD92.4%Sector ExposureHealth Care95.5%Industry ExposureBiotechnology76.3%Pharmaceuticals6.2%Health Care Technology4.3%Health Care Providers & Services2.0%Diversified Consumer Services1.9%Health Care Equipment & Supplies1.3%SubIndustry ExposureBiotechnology75.9%Pharmaceuticals6.2%Health Care Distributors4.3%Life Sciences Tools & Services3.1%Health Care Services2.0% Related Companies and Tools Related Companies Horizon Kinetics Medical ETF Portfolio Companies JPMorgan Healthcare Leaders ETF Portfolio Companies ProShares UltraShort Nasdaq Biotechnology Portfolio Companies Invesco Nasdaq Biotechnology ETF Portfolio Companies F/m Emerald Life Sciences Innovation ETF Portfolio Companies ProShares Ultra Nasdaq Biotechnology Portfolio Companies Invesco Dorsey Wright Healthcare Momentum ETF Portfolio Companies Invesco S&P SmallCap Health Care ETF Portfolio Companies VanEck Biotech ETF Portfolio Companies VanEck Pharmaceutical ETF Portfolio Companies This page (NASDAQ:FTXH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | SponsoredHow to trade Executive Order 14154Trump’s pen must be running out of ink… Since he returned to office he’s signed more than 50 Executive Orde...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Nasdaq Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Nasdaq Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.